复锐医疗科技（01696）于2026年11月6日公告，当日于香港联交所场内回购14,800股普通股，约占此前已发行股本的0.003%。本次回购价格区间介乎每股1.775港元至1.800港元，总金额26,558港元（约合2.66万港元）。
回购完成后，公司已发行股份数量相应从467,443,892股降至467,429,092股，库藏股数量增至914,000股，总已发行股份数保持在468,343,092股。公司表示，是次回购基于其于2026年6月24日通过的一般授权。截至最新数据，公司可根据该授权回购的剩余股份数量为46,834,309股。
公告确认，其回购操作符合香港联合交易所有限公司证券上市规则及有关法律法规，并由公司董事会正式批准。本公告由公司秘书方前厉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.